Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- Check2 days agoChange DetectedA new Revision: v3.5.4 tag was added, and references to Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.5.3 were removed, indicating a refresh of the page's versioning and topic references.SummaryDifference0.2%

- Check9 days agoChange DetectedNo textual changes were detected in the supplied change data; the page content appears unchanged based on the information given.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page now includes related topic links for Melanoma and MedlinePlus Genetics in the MedlinePlus related topics section, providing quick access to consumer health information.SummaryDifference0.2%

- Check23 days agoChange DetectedThe page’s footer revision/version was updated to **v3.5.3**. This reflects a metadata/version update rather than a substantive change to the trial information.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded Melanoma as a topic tag and included related topics via MedlinePlus Genetics. Updated the page revision from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check37 days agoChange DetectedRemoved the Melanoma related topic from the related topics section and deleted the MedlinePlus Genetics related topic (including the related topics header).SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.